{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:19:01Z","timestamp":1791299941619,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/inf.0b013e31822539f6","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T04:50:49Z","timestamp":1309927849000},"page":"974-979","source":"Crossref","is-referenced-by-count":47,"title":["Antiretroviral Therapy Responses Among Children Attending a Large Public Clinic in Soweto, South Africa"],"prefix":"10.1097","volume":"30","author":[{"given":"Tammy M.","family":"Meyers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Yotebieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Moultrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210202","article-title":"AIDS epidemic update.","year":"2007"},{"key":"R2-13-20210202","article-title":"Towards universal access: scaling up priority HIV\/AIDS interventions in the health sector: progress report 2010.","year":"2010"},{"key":"R3-13-20210202","article-title":"Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach (2010 revision).","year":"2010"},{"key":"R4-13-20210202","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1000931","article-title":"Antiretroviral treatment for children with peripartum nevirapine exposure.","volume":"363","author":"Palumbo","year":"2010","journal-title":"N Engl J Med"},{"key":"R5-13-20210202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1473-3099(08)70180-4","article-title":"Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.","volume":"8","author":"Sutcliffe","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R6-13-20210202","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1086\/648079","article-title":"Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis.","volume":"49","author":"Ciaranello","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R7-13-20210202","article-title":"Antiretroviral drugs and the prevention of mother-to-child transmission of HIV infection in resource-limited settings. Recommendations for a public health approach (2005 revision).","year":"2005"},{"key":"R8-13-20210202","article-title":"Guidelines for the Management of HIV-Infected Children \u2013 2005, Health. 1st ed.","author":"Meyers","year":"2005"},{"key":"R9-13-20210202","article-title":"Guidelines for the Management of HIV infected Children.","year":"2005"},{"key":"R10-13-20210202","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.48.5.1553-1560.2004","article-title":"Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers.","volume":"48","author":"la Porte","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-13-20210202","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cyto.10068","article-title":"CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration.","volume":"50","author":"Glencross","year":"2002","journal-title":"Cytometry"},{"key":"R13-13-20210202","article-title":"WHO child growth standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height, and body mass index-for-age: methods and development.","year":"2006"},{"key":"R14-13-20210202","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.298.16.1888","article-title":"Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.","volume":"298","author":"Bolton-Moore","year":"2007","journal-title":"JAMA"},{"key":"R15-13-20210202","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.296.7.782","article-title":"Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.","volume":"296","author":"Stringer","year":"2006","journal-title":"JAMA"},{"key":"R16-13-20210202","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1097\/QAD.0b013e32801086b0","article-title":"Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi.","volume":"20","author":"Zachariah","year":"2006","journal-title":"AIDS"},{"key":"R17-13-20210202","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E","article-title":"Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data.","volume":"16","author":"Cnaan","year":"1997","journal-title":"Stat Med"},{"key":"R18-13-20210202","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","article-title":"Checking the Cox model with cumulative sums of martingale-based residuals.","volume":"80","author":"Lin","year":"1993","journal-title":"Biometrika"},{"key":"R19-13-20210202","first-page":"730","article-title":"Outcomes of the South African National Antiretroviral Treatment programme for children: the IeDEA Southern Africa collaboration.","volume":"99","author":"Davies","year":"2009","journal-title":"S Afr Med J"},{"key":"R20-13-20210202","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"R21-13-20210202","first-page":"988","article-title":"Antiretroviral treatment for children.","volume":"96","author":"Eley","year":"2006","journal-title":"S Afr Med J"},{"key":"R22-13-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2431-7-13","article-title":"Preliminary outcomes of a pediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.","volume":"7","author":"Reddi","year":"2007","journal-title":"BMC Pediatr"},{"key":"R23-13-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006454-200301000-00015","article-title":"Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.","volume":"22","author":"Gibb","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R24-13-20210202","article-title":"Global tuberculosis control 2010.","year":"2010"},{"key":"R25-13-20210202","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00002030-200305020-00023","article-title":"Lopinavir: acute exposure inhibits P-glycoprotein; extended exposure induces P-glycoprotein.","volume":"17","author":"Vishnuvardhan","year":"2003","journal-title":"AIDS"},{"key":"R26-13-20210202","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1128\/AAC.42.12.3218","article-title":"ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease.","volume":"42","author":"Sham","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-13-20210202","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/AAC.00461-06","article-title":"Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers.","volume":"50","author":"Burger","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-13-20210202","article-title":"Applied Pharmacokinetics and Pharmakodynamics: Principles of Therapeutic Drug Monitoring. 4th ed.","author":"Burton","year":"2005"},{"key":"R29-13-20210202","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.48.5.1553-1560.2004","article-title":"Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers.","volume":"48","author":"La Porte CJ CE, Bertz","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-13-20210202","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3851\/IMP1455","article-title":"Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries.","volume":"14","author":"Maartens","year":"2009","journal-title":"Antivir Ther"},{"key":"R32-13-20210202","doi-asserted-by":"crossref","first-page":"e17273","DOI":"10.1371\/journal.pone.0017273","article-title":"Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment.","volume":"6","author":"Frohoff","year":"2011","journal-title":"PLoS One"},{"key":"R33-13-20210202","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1086\/595553","article-title":"Virologic suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy.","volume":"48","author":"Muller","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R34-13-20210202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/QAD.0b013e328332d5ca","article-title":"Six-month gain in weight, height, and CD4 predict subsequent antiretroviral treatment responses in HIV-infected South African children.","volume":"24","author":"Yotebieng","year":"2010","journal-title":"AIDS"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e31822539f6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:37:47Z","timestamp":1786045067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201111000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31822539f6","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}